<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: To determine whether meibomian gland disease, a major contributor to <z:e sem="disease" ids="C0013238" disease_type="Disease or Syndrome" abbrv="">dry eye syndrome</z:e>, is associated with <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>DESIGN: Retrospective case-control study </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: setting: Clinical practice. patient or study population: Sixty-six patients from January 2008 to July 2009 with moderate to severe meibomian gland disease whose serum <z:chebi fb="23" ids="18059">lipid</z:chebi> levels were obtained </plain></SENT>
<SENT sid="3" pm="."><plain>We excluded patients who were already taking <z:chebi fb="23" ids="18059">lipid</z:chebi>-altering substances and patients with rheumatologic disease </plain></SENT>
<SENT sid="4" pm="."><plain>We analyzed several parameters in prevalence of <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e> (total cholesterol &gt; 200 mg/dL, <z:chebi fb="2" ids="39026">low-density lipoprotein</z:chebi> [<z:chebi fb="15" ids="39026">LDL</z:chebi>] &gt; 130 mg/dL, <z:chebi fb="6" ids="39025">high-density lipoprotein</z:chebi> [<z:chebi fb="17" ids="39025">HDL</z:chebi>] &lt; 40 mg/dL, and <z:chebi fb="4" ids="17855">triglycerides</z:chebi> &gt;150 mg/dL) in MGD patients and compared these patients to the general population as reported by data from the National Health and Nutrition Examination Survey (NHANES). main outcome measure: The prevalence of <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e> (<z:hpo ids='HP_0003124'>elevated total cholesterol</z:hpo>, elevated <z:chebi fb="15" ids="39026">LDL</z:chebi>, decreased <z:chebi fb="17" ids="39025">HDL</z:chebi>, or elevated <z:chebi fb="4" ids="17855">triglycerides</z:chebi>) in patients with moderate to severe MGD </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Patients with moderate to severe MGD had a higher incidence of <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e> with respect to <z:hpo ids='HP_0003124'>elevated total cholesterol</z:hpo> (&gt;200 mg/dL), 67.4% to 45.1% (P = .0012) when compared to population controls </plain></SENT>
<SENT sid="6" pm="."><plain>There was a smaller number of MGD patients with low <z:chebi fb="17" ids="39025">HDL</z:chebi> (<z:chebi fb="17" ids="39025">HDL</z:chebi> &lt; 40 mg/dL), 6.5%, when compared to controls, 15.7% (P = .045) </plain></SENT>
<SENT sid="7" pm="."><plain>The incidence of increased <z:chebi fb="15" ids="39026">LDL</z:chebi> was not statistically significant (P = .184) </plain></SENT>
<SENT sid="8" pm="."><plain>There was a statistically smaller number of MGD patients with high <z:chebi fb="4" ids="17855">triglycerides</z:chebi> (TG &gt; 150 mg/dL), 15.2%, when compared to controls, 33.1% (P = .0049) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Patients with moderate to severe MGD have a higher incidence of <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e> with respect to <z:hpo ids='HP_0003124'>elevated total cholesterol</z:hpo> than the general population </plain></SENT>
<SENT sid="10" pm="."><plain>Surprisingly, the component of total cholesterol that contributed most to this increase in total cholesterol came from elevated serum <z:chebi fb="17" ids="39025">HDL</z:chebi> levels </plain></SENT>
<SENT sid="11" pm="."><plain>To our knowledge, elevated <z:chebi fb="17" ids="39025">HDL</z:chebi> has not been associated with any pathologic state </plain></SENT>
<SENT sid="12" pm="."><plain>Patients with MGD had a statistically significant lower incidence of <z:e sem="disease" ids="C0473527" disease_type="Disease or Syndrome" abbrv="">hypoalphalipoproteinemia</z:e> (low <z:chebi fb="17" ids="39025">HDL</z:chebi>) than the general population </plain></SENT>
<SENT sid="13" pm="."><plain>Patients with MGD also had a lower incidence of <z:hpo ids='HP_0002155'>hypertriglyceridemia</z:hpo> than the general population </plain></SENT>
</text></document>